Danaher Corp

DHR

Equity

ISIN null / Valor 923916

New York Stock Exchange, Inc (2026-02-20)

USD 209.50-0.83%

Danaher Corp
UMushroom community rating:

4.25 2 votes No rating yet

NegativeNeutralPositive

About company

Danaher Corporation is a globally recognized conglomerate with a diverse portfolio that includes a significant presence in the biotechnology sector through its subsidiary, Cytiva. This segment of Danaher's business specializes in providing a comprehensive range of technologies, services, and expertise aimed at supporting the research, development, and manufacturing processes within the biopharmaceutical industry. Cytiva plays a crucial role in facilitating the advancement of therapeutics by offering solutions that enhance the safety and efficiency of developing and commercializing a wide array of medical treatments, including life-saving vaccines, biologic drugs, and innovative cell and gene therapies. Through its focus on innovation and customer support, Danaher, via Cytiva, contributes significantly to the progress of healthcare and the availability of advanced therapeutic options.

Summarized from source with an LLMView SourceSector: Industrials

Latest Results ():

Summarized from source with an LLMView Source

Key figures

0.75%1Y

-7.70%3Y

2.30%5Y

Performance

33.0%1Y

29.0%3Y

29.1%5Y

Volatility